AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 119 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $365,000 | +22.9% | 38,800 | 0.0% | 0.04% | +14.7% |
Q2 2020 | $297,000 | +23.8% | 38,800 | 0.0% | 0.03% | 0.0% |
Q1 2020 | $240,000 | -49.2% | 38,800 | 0.0% | 0.03% | -39.3% |
Q4 2019 | $472,000 | +5.4% | 38,800 | 0.0% | 0.06% | +5.7% |
Q3 2019 | $448,000 | +15.5% | 38,800 | 0.0% | 0.05% | +10.4% |
Q2 2019 | $388,000 | -22.4% | 38,800 | 0.0% | 0.05% | -27.3% |
Q1 2019 | $500,000 | -15.1% | 38,800 | 0.0% | 0.07% | -25.0% |
Q4 2018 | $589,000 | -24.1% | 38,800 | 0.0% | 0.09% | -4.3% |
Q3 2018 | $776,000 | -14.6% | 38,800 | -16.7% | 0.09% | +10.8% |
Q2 2018 | $909,000 | -3.2% | 46,600 | 0.0% | 0.08% | -8.8% |
Q1 2018 | $939,000 | +52.2% | 46,600 | 0.0% | 0.09% | +54.2% |
Q4 2017 | $617,000 | -32.6% | 46,600 | -6.0% | 0.06% | -28.0% |
Q3 2017 | $915,000 | +0.3% | 49,600 | 0.0% | 0.08% | -2.4% |
Q2 2017 | $912,000 | -18.4% | 49,600 | 0.0% | 0.08% | -20.0% |
Q1 2017 | $1,118,000 | -16.3% | 49,600 | +29.2% | 0.10% | +54.4% |
Q4 2016 | $1,336,000 | – | 38,400 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |